Boston Scientific Corp. has filed two patent infringement cases against Edwards Lifesciences Corp., alleging Edwards’ Sapien 3 transcatheter aortic valve replacement (TAVR) and its delivery systems violate several patents held by the Marlborough, Mass.-based device-maker. The cases echo claims made in a pending case filed in Germany last fall.
One complaint, filed in California’s Central District court, alleges that Edwards’ Commander, Ascendra+, Certitude, Novaflex+ and RetroFlex 3...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?